AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462 | +33.5% | 10,057 | +66.8% | 0.01% | +66.7% |
| Q2 2023 | $346 | -71.1% | 6,029 | -81.1% | 0.00% | -80.0% |
| Q1 2023 | $1,198 | +142.0% | 31,947 | +80.6% | 0.02% | +114.3% |
| Q4 2022 | $495 | -99.9% | 17,693 | +43.4% | 0.01% | +40.0% |
| Q2 2022 | $429,000 | +57.7% | 12,340 | -13.8% | 0.01% | +150.0% |
| Q3 2021 | $272,000 | -62.5% | 14,315 | -60.3% | 0.00% | -71.4% |
| Q2 2021 | $726,000 | +178.2% | 36,048 | +209.3% | 0.01% | -12.5% |
| Q2 2020 | $261,000 | – | 11,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |